Five Things To Look For In The Coming Year In Healthcare/Life Sciences
Mohr Davidow's Sue Siegel shares promising areas for healthcare and life sciences investments in in 2011 in this contributed article for Xconomy.
In 2011 and into this next decade, the rate of data generation from biological measurement will continue to accelerate. Making sense of this deluge of data from sources as disparate as electronic medical records, biometric sensors, population statistics, environmental factors, and genomics will be the interesting part! Nimble start‐ups that can aggregate and analyze these data will create tremendous value and advances in human health without the capital intensity of traditional healthcare companies.